Klemz Kevin M's Form 4 filing
Silk Road Medical Inc (SILK) · filed Mar 5, 2024
- Accession no.
- 0001593968-24-000431
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $42.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klemz Kevin MCIK 0001384749 | Officer (EVP/Chief Legal Officer/Sec.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +42,818 | $0.00 | $0 | 167,691 | Direct | |
| Mar 5, 2024 | Common Stock | SSaleDisposed | −2,497 | $17.17 | −$42,873.49 | 165,194 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.